Article
Off Label Use of Tenecteplase in the Management of High-Risk Pulmonary Embolism
2024-05-24
Abstract excerpt
<h4>Background: </h4> Pulmonary embolism (PE) is a common multifactorial disease, but high-risk PE s a life-threatening condition associated with high mortality and morbidity and a heavy prognostic burden. Systemic thrombolysis is the first-line treatment approach for severe high-risk PE, but only few agents are indicated for use by international guidelines. Tenecteplase, a thrombolytic agent, is proven to reduce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 200edcb0-f43e-5d74-97b2-c1244bdf2de7
- DOI
- 10.20944/preprints202405.1536.v1
